Aspirin in “Compensated” Cirrhosis: Does the Evidence Concern First or Recurrent Decompensation?
Journal of Gastroenterology and Hepatology · 04.11.2026
DOI: 10.1111/jgh.70867 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 04.11.2026. Verfasst von Liverinto-Panagiotis Mela und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, General Hospital of Chalkida, Chalkida, Greece. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Internal Medicine, General Hospital of Chalkida, Chalkida, Greece.
- School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
ORCID-Profile: Liverinto-Panagiotis Mela, Sofia Spirakou, Melina Mela
Zitieren
APA
Mela, L. P., Spirakou, S., & Mela, M. (2026). Aspirin in “Compensated” Cirrhosis: Does the Evidence Concern First or Recurrent Decompensation?. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70867
Vancouver
Mela LP, Spirakou S, Mela M. Aspirin in “Compensated” Cirrhosis: Does the Evidence Concern First or Recurrent Decompensation?. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70867
BibTeX
@article{Mela2026,
author = {Mela, Liverinto-Panagiotis and Spirakou, Sofia and Mela, Melina},
title = {Aspirin in “Compensated” Cirrhosis: Does the Evidence Concern First or Recurrent Decompensation?},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
doi = {10.1111/jgh.70867}
}
EUVIMED